KERASOS

The KERASOS project is dedicated to tackling Dry Eye Syndrome (DES), a multifactorial ocular condition that affects millions of people worldwide. The primary objective of the project is to develop a diagnostic tool capable of providing more accurate and early identification of the different subtypes of the disease, including evaporative and aqueous-deficient dry eye. To achieve this, KERASOS employs a molecular biomarker-based approach, offering detailed insights into the pathophysiological processes underlying the disorder.

A key innovation of the project is the development of a Point-of-Care (PoC)device that facilitates the collection and analysis of epithelial samples directly in clinical settings. This enables ophthalmologists to deliver more personalized and effective treatments. By improving diagnostic accuracy, this technology also helps reduce the costs associated with dry eye treatment and the numerous consultations typically required for its management.

Beyond diagnosis, KERASOS has the potential to pave the way for targeted therapies derived from the biomarkers identified during the project, advancing the field of ophthalmology and offering new hope for patients.